OPN promotes survival of activated T cells by up-regulating CD44 in patients with oral lichen planus

Clinical Immunology

Volumn 138, Issue 3, 2011, Pages 291-298

  Liu, Gui Xiang ^a,b   Sun, Jin Tang ^b   Yang, Mei Xiang ^b   Qi, Xiang Min ^a   Shao, Qian Qian ^b   Xie, Qi ^b   Qu, Xun ^b   Wei, Feng Cai ^b   Sun, Shan Zhen ^a  

^a People's Republic of China   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Apoptosis; CD44; Granzyme B (GrB); Oral lichen planus (OLP); Osteopontin (OPN)

Indexed keywords

GRANZYME B; HERMES ANTIGEN; OSTEOPONTIN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BIOACCUMULATION; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LICHEN PLANUS; LYMPHOCYTIC INFILTRATION; MOUTH DISEASE; MOUTH LICHEN PLANUS; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ANTIGENS, CD3; ANTIGENS, CD44; APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; GRANZYMES; HUMANS; LEUKOCYTES, MONONUCLEAR; LICHEN PLANUS, ORAL; MOUTH MUCOSA; UP-REGULATION;

EID: 79851512840     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.12.007     Document Type: Article

References (34)

1. Khan A., Farah C.S., Savage N.W., Walsh L.J., Harbrow D.J., Sugerman P.B. Th1 cytokines in oral lichen planus. J. Oral Pathol. Med. 2003, 32:77-83.
2. Srinivasan M., Kodumudi K.N., Zunt S.L. Soluble CD14 and toll-like receptor-2 are potential salivary biomarkers for oral lichen planus and burning mouth syndrome. Clin. Immunol. 2008, 126:31-37.
3. E. Torrente-Castells, R. Figueiredo, L. Berini-Aytes, and C. Gay-Escoda, Clinical features of oral lichen planus. A retrospective study of 65 cases. Med. Oral Patol. Oral Cir. Bucal 15 (2010) e685-690.
4. Cortes-Ramirez D.A., Gainza-Cirauqui M.L., Echebarria-Goikouria M.A., Aguirre-Urizar J.M. Oral lichenoid disease as a premalignant condition: the controversies and the unknown. Med. Oral Patol. Oral Cir. Bucal 2009, 14:E118-E122.
5. Sugerman P.B., Savage N.W., Walsh L.J., Zhao Z.Z., Zhou X.J., Khan A., Seymour G.J., Bigby M. The pathogenesis of oral lichen planus. Crit. Rev. Oral Biol. Med. 2002, 13:350-365.
6. Zhou Z.T., Wei B.J., Shi P. Osteopontin expression in oral lichen planus. J. Oral Pathol. Med. 2008, 37:94-98.
7. Porter S.R., Kirby A., Olsen I., Barrett W. Immunologic aspects of dermal and oral lichen planus: a review. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 1997, 83:358-366.
8. Farmer E.R. The histopathology of graft-versus-host disease. Adv. Dermatol. 1986, 1:173-188.
9. Boyd A.S., Neldner K.H. Lichen planus. J. Am. Acad. Dermatol. 1991, 25:593-619.
10. Santoro A., Majorana A., Bardellini E., Gentili F., Festa S., Sapelli P., Facchetti F. Cytotoxic molecule expression and epithelial cell apoptosis in oral and cutaneous lichen planus. Am. J. Clin. Pathol. 2004, 121:758-764.
11. Iijima W., Ohtani H., Nakayama T., Sugawara Y., Sato E., Nagura H., Yoshie O., Sasano T. Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism. Am. J. Pathol. 2003, 163:261-268.
12. Bascones-Ilundain C., Gonzalez-Moles M.A., Esparza-Gomez G., Gil-Montoya J.A., Bascones-Martinez A. Importance of apoptotic mechanisms in inflammatory infiltrate of oral lichen planus lesions. Anticancer Res. 2006, 26:357-362.
13. Deng G.H., Chen Z.L., Chen H.B., Cheng J. Significance of cell immunoreactions and cell apoptosis in oral lichen planus. Hua Xi Kou Qiang Yi Xue Za Zhi 2009, 27:256-259.
14. Ashkar S., Weber G.F., Panoutsakopoulou V., Sanchirico M.E., Jansson M., Zawaideh S., Rittling S.R., Denhardt D.T., Glimcher M.J., Cantor H. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000, 287:860-864.
15. Kang J.A., Zhou Y., Weis T.L., Liu H., Ulaszek J., Satgurunathan N., Zhou L., van Besien K., Crispino J., Verma A., Low P.S., Wickrema A. Osteopontin regulates actin cytoskeleton and contributes to cell proliferation in primary erythroblasts. J. Biol. Chem. 2008, 283:6997-7006.
16. Renkl A.C., Wussler J., Ahrens T., Thoma K., Kon S., Uede T., Martin S.F., Simon J.C., Weiss J.M. Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype. Blood 2005, 106:946-955.
17. O'Regan A.W., Nau G.J., Chupp G.L., Berman J.S. Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks. Immunol. Today 2000, 21:475-478.
18. Ponta H., Sherman L., Herrlich P.A. CD44: from adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell Biol. 2003, 4:33-45.
19. Gunthert U., Schwarzler C., Wittig B., Laman J., Ruiz P., Stauder R., Bloem A., Smadja-Joffe F., Zoller M., Rolink A. Functional involvement of CD44, a family of cell adhesion molecules, in immune responses, tumour progression and haematopoiesis. Adv. Exp. Med. Biol. 1998, 451:43-49.
20. Stoop R., Gal I., Glant T.T., McNeish J.D., Mikecz K. Trafficking of CD44-deficient murine lymphocytes under normal and inflammatory conditions. Eur. J. Immunol. 2002, 32:2532-2542.
21. Yang J., Ahn C., Jung H.K., Kim E.K., Kim J.Y., Kim Y.S., Han J.S., Kim S., Lee J.S. The expression patterns of CD44 and CD45RB on peripheral blood T lymphocytes in the rejection of allogeneic murine skin transplantation. Transpl. Immunol. 2003, 11:197-206.
22. Lee J.L., Wang M.J., Sudhir P.R., Chen G.D., Chi C.W., Chen J.Y. Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells. Cancer Res. 2007, 67:2089-2097.
23. Prpic Massari L., Kastelan M., Gruber F., Laskarin G., Sotosek Tokmadzic V., Strbo N., Zamolo G., Zauhar G., Rukavina D. Perforin expression in peripheral blood lymphocytes and skin-infiltrating cells in patients with lichen planus. Br. J. Dermatol. 2004, 151:433-439.
24. Kunkel E.J., Butcher E.C. Chemokines and the tissue-specific migration of lymphocytes. Immunity 2002, 16:1-4.
25. Campbell J.J., Haraldsen G., Pan J., Rottman J., Qin S., Ponath P., Andrew D.P., Warnke R., Ruffing N., Kassam N., Wu L., Butcher E.C. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999, 400:776-780.
26. Rafi A., Nagarkatti M., Nagarkatti P.S. Hyaluronate-CD44 interactions can induce murine B-cell activation. Blood 1997, 89:2901-2908.
27. Rafi-Janajreh A.Q., Nagarkatti P.S., Nagarkatti M. Role of CD44 in CTL and NK cell activity. Front. Biosci. 1998, 3:d665-d671.
28. Triggle C.R., Ding H., Anderson T.J., Pannirselvam M. The endothelium in health and disease: a discussion of the contribution of non-nitric oxide endothelium-derived vasoactive mediators to vascular homeostasis in normal vessels and in type II diabetes. Mol. Cell. Biochem. 2004, 263:21-27.
29. Laforge M., Bidere N., Carmona S., Devocelle A., Charpentier B., Senik A. Apoptotic death concurrent with CD3 stimulation in primary human CD8+ T lymphocytes: a role for endogenous granzyme B. J. Immunol. 2006, 176:3966-3977.
30. Zheng L., Fisher G., Miller R.E., Peschon J., Lynch D.H., Lenardo M.J. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 1995, 377:348-351.
31. Zimmermann C., Rawiel M., Blaser C., Kaufmann M., Pircher H. Homeostatic regulation of CD8+ T cells after antigen challenge in the absence of Fas (CD95). Eur. J. Immunol. 1996, 26:2903-2910.
32. Chowdhury D., Lieberman J. Death by a thousand cuts: granzyme pathways of programmed cell death. Annu. Rev. Immunol. 2008, 26:389-420.
33. Classen C.F., Bird P.I., Debatin K.M. Modulation of the granzyme B inhibitor proteinase inhibitor 9 (PI-9) by activation of lymphocytes and monocytes in vitro and by Epstein-Barr virus and bacterial infection. Clin. Exp. Immunol. 2006, 143:534-542.
34. Yamamoto N., Sakai F., Kon S., Morimoto J., Kimura C., Yamazaki H., Okazaki I., Seki N., Fujii T., Uede T. Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. J. Clin. Invest. 2003, 112:181-188.